ITT Reports 2016 Fourth-Quarter and Full-Year Results, 2017 Guidance
ITT to Participate in Gabelli & Company’s 27th Annual Pump, Valve and Water Systems Symposium
Gabelli & Company’s 27th Annual Pump, Valve & Water Systems Symposium
Phase II Study Supports Potential for Genentech’s Tecentriq® (Atezolizumab) Plus Avastin® (Bevacizumab) for People With Locally Advanced or Metastatic Renal Cell Carcinoma
Aeterna Zentaris Announces Plans to Pursue FDA Registration of Macrilen™
Harris Corporation Reports Fiscal 2017 Second Quarter Results
These nominees handled a wide range of assets with notable skill.